Quanterix (QTRX) Competitors $10.50 +0.51 (+5.11%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends QTRX vs. TRNS, CTKB, LAB, EYPT, AEHR, SENS, NAUT, QSI, FEIM, and KEQUShould you be buying Quanterix stock or one of its competitors? The main competitors of Quanterix include Transcat (TRNS), Cytek Biosciences (CTKB), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Senseonics (SENS), Nautilus Biotechnology (NAUT), Quantum-Si (QSI), Frequency Electronics (FEIM), and Kewaunee Scientific (KEQU). These companies are all part of the "measuring and control equipment" industry. Quanterix vs. Transcat Cytek Biosciences Standard BioTools EyePoint Pharmaceuticals Aehr Test Systems Senseonics Nautilus Biotechnology Quantum-Si Frequency Electronics Kewaunee Scientific Transcat (NASDAQ:TRNS) and Quanterix (NASDAQ:QTRX) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, community ranking, earnings, risk and media sentiment. Which has more risk and volatility, TRNS or QTRX? Transcat has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, Quanterix has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Do analysts prefer TRNS or QTRX? Transcat currently has a consensus target price of $130.25, suggesting a potential upside of 23.17%. Quanterix has a consensus target price of $23.25, suggesting a potential upside of 121.43%. Given Quanterix's stronger consensus rating and higher probable upside, analysts clearly believe Quanterix is more favorable than Transcat.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Transcat 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Quanterix 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has preferable valuation & earnings, TRNS or QTRX? Transcat has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTranscat$270.61M3.59$13.65M$1.9853.41Quanterix$127.95M3.15-$32.33M-$1.05-10.00 Does the media prefer TRNS or QTRX? In the previous week, Transcat had 3 more articles in the media than Quanterix. MarketBeat recorded 10 mentions for Transcat and 7 mentions for Quanterix. Quanterix's average media sentiment score of 0.33 beat Transcat's score of -0.39 indicating that Quanterix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Transcat 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Quanterix 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor TRNS or QTRX? Quanterix received 59 more outperform votes than Transcat when rated by MarketBeat users. However, 66.88% of users gave Transcat an outperform vote while only 61.56% of users gave Quanterix an outperform vote. CompanyUnderperformOutperformTranscatOutperform Votes21066.88% Underperform Votes10433.12% QuanterixOutperform Votes26961.56% Underperform Votes16838.44% Is TRNS or QTRX more profitable? Transcat has a net margin of 6.63% compared to Quanterix's net margin of -30.71%. Transcat's return on equity of 7.36% beat Quanterix's return on equity.Company Net Margins Return on Equity Return on Assets Transcat6.63% 7.36% 5.90% Quanterix -30.71%-11.52%-9.47% Do insiders and institutionals have more ownership in TRNS or QTRX? 98.3% of Transcat shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 2.3% of Transcat shares are owned by insiders. Comparatively, 6.9% of Quanterix shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryTranscat beats Quanterix on 11 of the 17 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Quanterix News Delivered to You Automatically Sign up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QTRX vs. The Competition Export to ExcelMetricQuanterixAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$402.98M$5.42B$5.12B$9.07BDividend YieldN/A0.43%4.91%4.22%P/E Ratio-10.0025.1891.3417.19Price / Sales3.154.291,117.70116.80Price / CashN/A44.4542.6437.86Price / Book1.152.204.794.78Net Income-$32.33M$2.05M$120.07M$225.60M7 Day Performance-1.69%-2.70%-1.90%-1.23%1 Month Performance-10.64%-2.89%11.45%3.37%1 Year Performance-62.00%-28.70%30.63%16.58% Quanterix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QTRXQuanterix2.0118 of 5 stars$10.50+5.1%$23.25+121.4%-60.9%$402.98M$127.95M-10.00460TRNSTranscat2.7544 of 5 stars$109.27+0.1%$130.25+19.2%+2.4%$1.01B$270.61M54.911,104Analyst RevisionNews CoverageCTKBCytek Biosciences2.0636 of 5 stars$6.43+3.5%$9.25+43.9%-32.3%$828.26M$201.21M-77.63500Positive NewsLABStandard BioTools3.2471 of 5 stars$2.12+11.0%$2.88+35.6%+3.6%$789.19M$155.90M-2.99620News CoveragePositive NewsGap DownEYPTEyePoint Pharmaceuticals1.9425 of 5 stars$7.49+0.4%$25.71+243.3%-63.3%$511.20M$45.71M-3.79120News CoverageGap DownAEHRAehr Test Systems2.6061 of 5 stars$14.40+24.9%$25.00+73.6%-47.8%$426.69M$58.71M13.0090News CoverageGap UpHigh Trading VolumeSENSSenseonics2.5018 of 5 stars$0.46+1.8%$2.00+339.6%-27.3%$270.88M$22.39M-3.4490Analyst ForecastGap DownHigh Trading VolumeNAUTNautilus Biotechnology1.625 of 5 stars$2.01+3.1%$3.58+78.3%-41.3%$252.38MN/A-3.48130QSIQuantum-Si1.9199 of 5 stars$1.54-10.8%$3.25+111.7%-25.3%$219.06M$2.27M-2.36150High Trading VolumeFEIMFrequency Electronics2.233 of 5 stars$18.45+10.4%N/A+92.5%$176.51M$60.19M22.07200Analyst UpgradeNews CoverageHigh Trading VolumeKEQUKewaunee Scientific2.258 of 5 stars$54.80+2.6%N/A+107.4%$157.39M$199.64M8.461,006Analyst UpgradeInsider TradeGap Down Related Companies and Tools Related Companies TRNS Alternatives CTKB Alternatives LAB Alternatives EYPT Alternatives AEHR Alternatives SENS Alternatives NAUT Alternatives QSI Alternatives FEIM Alternatives KEQU Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:QTRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quanterix Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quanterix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.